Serum amyloid A – a review
暂无分享,去创建一个
[1] H. Schatten,et al. Activation of Sp1 and Its Functional Co-operation with Serum Amyloid A-activating Sequence Binding Factor in Synoviocyte Cells Trigger Synergistic Action of Interleukin-1 and Interleukin-6 in Serum Amyloid A Gene Expression* , 1999, The Journal of Biological Chemistry.
[2] Joo-Yeon Yoo,et al. Innate and acquired immunity intersect in a global view of the acute-phase response , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[3] R. Zinkernagel,et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.
[4] G. Glenner,et al. X-RAY DIFFRACTION STUDIES ON AMYLOID FILAMENTS , 1968, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[5] N. Webb,et al. Nascent HDL formation by hepatocytes is reduced by the concerted action of serum amyloid A and endothelial lipase , 2011, Journal of Lipid Research.
[6] K. Higuchi,et al. AA amyloidosis-resistant CE/J mice have Saa1 and Saa2 genes that encode an identical SAA isoform , 2014, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[7] K. Hagihara,et al. Essential role of STAT3 in cytokine‐driven NF‐κB‐mediated serum amyloid A gene expression , 2005, Genes to cells : devoted to molecular & cellular mechanisms.
[8] A. Daugherty,et al. Deficiency of Endogenous Acute Phase Serum Amyloid A Does Not Affect Atherosclerotic Lesions in Apolipoprotein E–Deficient Mice , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[9] L. Maquat,et al. A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. , 1998, Trends in biochemical sciences.
[10] F. Askin,et al. Mycobacterial catalase–peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis , 2005, The Journal of experimental medicine.
[11] A. Whitehead,et al. A constitutively expressed serum amyloid A protein gene (SAA4) is closely linked to, and shares structural similarities with, an acute-phase serum amyloid A protein gene (SAA2). , 1993, Genomics.
[12] Junjie Yao,et al. Cross-seeding and cross-competition in mouse apolipoprotein A-II amyloid fibrils and protein A amyloid fibrils. , 2007, The American journal of pathology.
[13] V. Dixit,et al. Signaling in innate immunity and inflammation. , 2012, Cold Spring Harbor perspectives in biology.
[14] R. P. Ross,et al. Evaluation of colostrum-derived human mammary-associated serum amyloid A3 (M-SAA3) protein and peptide derivatives for the prevention of enteric infection: in vitro and in murine models of intestinal disease. , 2009, FEMS immunology and medical microbiology.
[15] T. Sawamura,et al. Human Serum Amyloid A3 (SAA3) Protein, Expressed as a Fusion Protein with SAA2, Binds the Oxidized Low Density Lipoprotein Receptor , 2015, PloS one.
[16] J. McQualter,et al. Serum amyloid A opposes lipoxin A4 to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease , 2012, Proceedings of the National Academy of Sciences.
[17] J. Sipe. Part 2 Revised nomenclature for serum amyloid A(SAA) , 2009 .
[18] I. Kushner. THE PHENOMENON OF THE ACUTE PHASE RESPONSE * , 1982, Annals of the New York Academy of Sciences.
[19] B. Ray,et al. Transcriptional Induction of Matrix Metalloproteinase-9 in the Chondrocyte and Synoviocyte Cells Is Regulated via a Novel Mechanism: Evidence for Functional Cooperation between Serum Amyloid A-Activating Factor-1 and AP-11 , 2005, The Journal of Immunology.
[20] S. Tam,et al. Macrophage cholesterol efflux and the active domains of serum amyloid A 2.1 Published, JLR Papers in Press, September 1, 2003. DOI 10.1194/jlr.M300133-JLR200 , 2003, Journal of Lipid Research.
[21] M. A. Larson,et al. Staphylococcus aureus lipotechoic acid induces differential expression of bovine serum amyloid A3 (SAA3) by mammary epithelial cells: Implications for early diagnosis of mastitis. , 2006, Veterinary immunology and immunopathology.
[22] S. Kennel,et al. The pattern recognition reagents RAGE VC1 and peptide p5 share common binding sites and exhibit specific reactivity with AA amyloid in mice , 2016, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[23] B. Burke,et al. Systemic amyloidosis complicating cystic fibrosis. A retrospective pathologic study. , 1986, Archives of pathology & laboratory medicine.
[24] Avrum Spira,et al. Hepatocyte-specific mutation of both NF-κB RelA and STAT3 abrogates the acute phase response in mice. , 2012, The Journal of clinical investigation.
[25] V. Fuster,et al. CANTOS: A Gigantic Proof-of-Concept Trial. , 2017, Circulation research.
[26] D. Mack,et al. The Conserved TFLK Motif of Mammary-Associated Serum Amyloid A3 Is Responsible for Up-regulation of Intestinal MUC3 Mucin Expression In Vitro , 2003, Pediatric Research.
[27] K. Sletten,et al. Massive Vascular AA‐Amyloidosis: A Histologically and Biochemically Distinctive Subtype of Reactive Systemic Amyloidosis , 1989, Scandinavian journal of immunology.
[28] I. Kushner,et al. Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.
[29] S. Tam,et al. Promoting export of macrophage cholesterol: the physiological role of a major acute-phase protein, serum amyloid A 2.1. , 2002, Journal of lipid research.
[30] R. Meek,et al. Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation , 1986, The Journal of experimental medicine.
[31] J. Foldi,et al. Constitutive and NF-kappa B-like proteins in the regulation of the serum amyloid A gene by interleukin 1. , 1991, Cytokine.
[32] A. Roessner,et al. Proteolysis of AA amyloid fibril proteins by matrix metalloproteinases-1, -2, and -3. , 2001, The American journal of pathology.
[33] R. Hannon,et al. Anti-Inflammatory Role of the Murine Formyl-Peptide Receptor 2: Ligand-Specific Effects on Leukocyte Responses and Experimental Inflammation , 2010, The Journal of Immunology.
[34] F. D. de Beer,et al. Serum Amyloid A Is a Ligand for Scavenger Receptor Class B Type I and Inhibits High Density Lipoprotein Binding and Selective Lipid Uptake* , 2005, Journal of Biological Chemistry.
[35] D. Potter,et al. Induction of hepatic synthesis of serum amyloid A protein and actin. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[36] E. Ratner,et al. Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer , 2009, British Journal of Cancer.
[37] A. Ramy,et al. Maternal serum amyloid A level as a novel marker of primary unexplained recurrent early pregnancy loss , 2017, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[38] A. Aljada,et al. Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics. , 2006, The Journal of clinical endocrinology and metabolism.
[39] P. Walther,et al. Cellular mechanism of fibril formation from serum amyloid A1 protein , 2017, EMBO reports.
[40] T. Seemungal,et al. Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD , 2005, Chest.
[41] P. Manley,et al. Acute-phase serum amyloid A: Perspectives on its physiological and pathological roles , 2012, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[42] M. Siegel,et al. Regulation of Interleukin‐6 Gene Expression by Steroids a , 1995, Annals of the New York Academy of Sciences.
[43] H. P. Monteiro,et al. Is serum amyloid A an endogenous TLR4 agonist? , 2008, Journal of leukocyte biology.
[44] R. Ye,et al. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. , 2003, Blood.
[45] C. Serhan,et al. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor , 1994, The Journal of experimental medicine.
[46] Mark Sh. Levin,et al. Expression of Serum Amyloid A in Human Ovarian Epithelial Tumors: Implication for a Role in Ovarian Tumorigenesis , 2010, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[47] Choon-Sik Park,et al. Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer. , 2011, Journal of proteome research.
[48] J. Sleeman,et al. A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4 , 2014, Oncogene.
[49] P. Sharp,et al. Evolution of the serum amyloid A (SAA) protein superfamily. , 1994, Genomics.
[50] R. Stearman,et al. Transcriptional regulation of serum amyloid A gene expression. , 1986, The Journal of biological chemistry.
[51] M. Kindy,et al. Structure of the mouse Saa4 gene and its linkage to the serum amyloid A gene family. , 1996, Genomics.
[52] A. Meeker,et al. A fusion protein between serum amyloid A and staphylococcal nuclease—synthesis, purification, and structural studies , 1998, Proteins.
[53] Dan R. Littman,et al. Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.
[54] Thomas D. Wu,et al. Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples , 2011, BMC Medical Genomics.
[55] N. Vasudev,et al. Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer , 2010, British Journal of Cancer.
[56] D. Rader,et al. Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice. , 1999, Journal of lipid research.
[57] A. Chait,et al. Serum Amyloid A and Lipoprotein Retention in Murine Models of Atherosclerosis , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[58] J. Natvig,et al. A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils. , 1974, The Journal of clinical investigation.
[59] Andrew J. Lindsay,et al. Acute phase proteins in salmonids: evolutionary analyses and acute phase response. , 1997, Journal of immunology.
[60] P. Ridker,et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.
[61] G. Glenner,et al. Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[62] W. Koenig,et al. Antidiabetic PPAR&ggr;-Activator Rosiglitazone Reduces MMP-9 Serum Levels in Type 2 Diabetic Patients With Coronary Artery Disease , 2003 .
[63] M. Mccarty. THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD , 1947, The Journal of experimental medicine.
[64] K. Hagihara,et al. IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system. , 2004, Biochemical and biophysical research communications.
[65] N. Zachara,et al. Serum amyloid A1 (SAA1) protein in human colostrum , 2018, FEBS open bio.
[66] D. Mucida,et al. “A Sledgehammer Breaks Glass but Forges Steel”: Bacteria Adhesion Shapes Gut Immunity , 2015, Cell.
[67] Michael Kimelman,et al. Serum Amyloid A Binding to CLA-1 (CD36 and LIMPII Analogous-1) Mediates Serum Amyloid A Protein-induced Activation of ERK1/2 and p38 Mitogen-activated Protein Kinases* , 2005, Journal of Biological Chemistry.
[68] C. J. Rosenthal,et al. Isolation and partial characterization of SAA-an amyloid-related protein from human serum. , 1976, Journal of immunology.
[69] J. Cidlowski,et al. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors , 1995, Molecular and cellular biology.
[70] Masafumi Tanaka,et al. Effect of amino acid variations in the central region of human serum amyloid A on the amyloidogenic properties. , 2014, Biochemical and biophysical research communications.
[71] Hong Tang,et al. Adaptive immune cells temper initial innate responses , 2007, Nature Medicine.
[72] I. Schmid. AA , 1988, Catalysis from A to Z.
[73] A. Campa,et al. A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil. , 2000, Biochemical and biophysical research communications.
[74] C. Carty,et al. Association of genetic variation in serum amyloid-A with cardiovascular disease and interactions with IL6, IL1RN, IL1beta and TNF genes in the Cardiovascular Health Study. , 2009, Journal of atherosclerosis and thrombosis.
[75] J. Raynes,et al. The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I. , 2007, The Biochemical journal.
[76] M. Shimizu,et al. [Intestinal epithelial cells]. , 1997, Nihon rinsho. Japanese journal of clinical medicine.
[77] T. Eggerman,et al. CD36 Is a Novel Serum Amyloid A (SAA) Receptor Mediating SAA Binding and SAA-induced Signaling in Human and Rodent Cells* , 2010, The Journal of Biological Chemistry.
[78] N. Webb,et al. A brief elevation of serum amyloid A is sufficient to increase atherosclerosis[S] , 2015, Journal of Lipid Research.
[79] Wei Hu,et al. Biogenesis of HDL by SAA is dependent on ABCA1 in the liver in vivos⃞ Published, JLR Papers in Press, November 21, 2007. , 2008, Journal of Lipid Research.
[80] B. Christensen,et al. Breast Cancer DNA Methylation Profiles Are Associated with Tumor Size and Alcohol and Folate Intake , 2010, PLoS genetics.
[81] P. Libby,et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.
[82] R. Palmiter,et al. The acute phase reactant serum amyloid A (SAA3) is a novel substrate for degradation by the metalloproteinases collagenase and stromelysin. , 1993, Biochimica et biophysica acta.
[83] F. Filippin-Monteiro,et al. Serum Amyloid A in the Placenta and Its Role in Trophoblast Invasion , 2014, PloS one.
[84] Andreas J Bäumler,et al. Responses to amyloids of microbial and host origin are mediated through toll-like receptor 2. , 2009, Cell host & microbe.
[85] Z. Ackerman,et al. Expression of Serum Amyloid A, in Normal, Dysplastic, and Neoplastic Human Colonic Mucosa: Implication for a Role in Colonic Tumorigenesis , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[86] B. Taylor,et al. Genes for serum amyloid A proteins map to Chromosome 7 in the mouse , 2004, Molecular and General Genetics MGG.
[87] M. Hattori,et al. Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells , 2015, Cell.
[88] A. Whitehead,et al. Serum amyloid A, the major vertebrate acute-phase reactant. , 1999, European journal of biochemistry.
[89] D. Moller,et al. Sarcoidosis—scientific progress and clinical challenges , 2011, Nature Reviews Rheumatology.
[90] R. Ye,et al. Serum Amyloid A Is an Endogenous Ligand That Differentially Induces IL-12 and IL-231 , 2006, The Journal of Immunology.
[91] W. Liao,et al. Synergistic induction of mouse serum amyloid A3 promoter by the inflammatory mediators IL-1 and IL-6. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[92] R. Kisilevsky,et al. The Heparin/Heparan Sulfate-binding Site on Apo-serum Amyloid A , 1999, The Journal of Biological Chemistry.
[93] J. Raynes,et al. Serum Amyloid A Protein Binds to Outer Membrane Protein A of Gram-negative Bacteria* , 2005, Journal of Biological Chemistry.
[94] I. Kushner,et al. Kinetic modeling and mathematical analysis indicate that acute phase gene expression in Hep 3B cells is regulated by both transcriptional and posttranscriptional mechanisms. , 1995, The Journal of clinical investigation.
[95] A. Trumpp,et al. Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors , 2018, Proceedings of the National Academy of Sciences.
[96] G. Walz,et al. Sensitive cilia set up the kidney , 2007, Nature Medicine.
[97] J. Raynes,et al. Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. , 2006, Blood.
[98] P. Ranløv. The adoptive transfer of experimental mouse amyloidosis by intravenous injections of spleen cell extracts from casein-treated syngeneic donor mice. , 2009, Acta pathologica et microbiologica Scandinavica.
[99] Vilmundur Gudnason,et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.
[100] P. Libby,et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.
[101] A. Shakya,et al. Serum Amyloid A-Activating Factor-1 (SAF-1) Transgenic Mice Are Prone to Develop a Severe Form of Inflammation-Induced Arthritis1 , 2004, The Journal of Immunology.
[102] K. Feingold,et al. The acute phase response inhibits reverse cholesterol transport1 , 2010, Journal of Lipid Research.
[103] Dehner Lp,et al. Systemic amyloidosis complicating cystic fibrosis. A retrospective pathologic study. , 1986 .
[104] A. Cohen,et al. Electron Microscopic Observations on a Fibrous Component in Amyloid of Diverse Origins , 1959, Nature.
[105] M. Benson,et al. Autocrine induction of collagenase by serum amyloid A-like and beta 2-microglobulin-like proteins. , 1989, Science.
[106] R. Kane,et al. Pathogenic Serum Amyloid A 1.1 Shows a Long Oligomer-rich Fibrillation Lag Phase Contrary to the Highly Amyloidogenic Non-pathogenic SAA2.2* , 2012, The Journal of Biological Chemistry.
[107] D. Burt,et al. Identification of cis-acting sequences responsible for phorbol ester induction of human serum amyloid A gene expression via a nuclear factor kappaB-like transcription factor , 1989, Molecular and cellular biology.
[108] J. Piette,et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 , 1999, Nature Genetics.
[109] F. Stevens. Hypothetical structure of human serum amyloid A protein , 2004, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[110] D. Smallwood,et al. Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.
[111] A. Chait,et al. Serum Amyloid A Facilitates the Binding of High-Density Lipoprotein From Mice Injected With Lipopolysaccharide to Vascular Proteoglycans , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[112] Ana I. Domingos,et al. An IL-23R/IL-22 Circuit Regulates Epithelial Serum Amyloid A to Promote Local Effector Th17 Responses , 2015, Cell.
[113] Shixun Wang,et al. Serum Amyloid A Induces a Vascular Smooth Muscle Cell Phenotype Switch through the p38 MAPK Signaling Pathway , 2017, BioMed research international.
[114] R. Ross,et al. Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry. , 1993, The American journal of pathology.
[115] M. Perretti,et al. Glucocorticoid upregulation of the annexin-A1 receptor in leukocytes. , 2006, Biochemical and biophysical research communications.
[116] G. Rice,et al. Phase II biomarker trial of a multimarker diagnostic for ovarian cancer , 2010, Journal of Cancer Research and Clinical Oncology.
[117] T. Shows,et al. Localization of human SAA gene(s) to chromosome 11 and detection of DNA polymorphisms. , 1986, Biochemical and biophysical research communications.
[118] D. Ron,et al. A family of constitutive C/EBP‐like DNA binding proteins attenuate the IL‐1 alpha induced, NF kappa B mediated trans‐activation of the angiotensinogen gene acute‐phase response element. , 1990, The EMBO journal.
[119] A. Butler,et al. Mapping of the mouse serum amyloid A gene cluster by long-range polymerase chain reaction , 2007, Immunogenetics.
[120] T. Strom,et al. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. , 1987, Journal of immunology.
[121] Hiroyuki Aburatani,et al. The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase , 2008, Nature Cell Biology.
[122] C. Brinckerhoff,et al. Serum amyloid A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin 1 induces synthesis of collagenase and is neutralized with specific antiserum. , 1991, The Journal of clinical investigation.
[123] Michael Y. Gerner,et al. Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism , 2018, Nature.
[124] C. Gieger,et al. Genome-Wide Association Study Identifies Two Novel Regions at 11p15.5-p13 and 1p31 with Major Impact on Acute-Phase Serum Amyloid A , 2010, PLoS genetics.
[125] Jonathan C. Betts,et al. Characterization of five human serum amyloid A1 alleles , 1994 .
[126] R. Ye,et al. Emerging functions of serum amyloid A in inflammation , 2015, Journal of leukocyte biology.
[127] J. Magarian Blander,et al. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function , 2010, The Journal of experimental medicine.
[128] Tuomas P. J. Knowles,et al. The amyloid state and its association with protein misfolding diseases , 2014, Nature Reviews Molecular Cell Biology.
[129] Wei Hu,et al. Serum amyloid A generates high density lipoprotein with cellular lipid in an ABCA1- or ABCA7-dependent manner Published, JLR Papers in Press, April 10, 2006. , 2006, Journal of Lipid Research.
[130] C. Thorn,et al. Tissue‐specific regulation of the human acute‐phase serum amyloid A genes, SAA1 and SAA2, by glucocorticoids in hepatic and epithelial cells , 2003, European journal of immunology.
[131] Mathias Jucker,et al. The Amyloid State of Proteins in Human Diseases , 2012, Cell.
[132] D. Potter,et al. Structure of the murine serum amyloid A gene family. Gene conversion. , 1986, The Journal of biological chemistry.
[133] Ji Ming Wang,et al. The cytokine-serum amyloid A-chemokine network. , 2016, Cytokine & growth factor reviews.
[134] D. Mack,et al. Elevated extrahepatic expression and secretion of mammary-associated serum amyloid A 3 (M-SAA3) into colostrum. , 2001, Veterinary immunology and immunopathology.
[135] Thomas Francis,et al. SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS , 1930, The Journal of experimental medicine.
[136] N. Eriksen,et al. AMYLOID. II. STARCH GEL ELECTROPHORETIC ANALYSIS OF SOME PROTEINS EXTRACTED FROM AMYLOID. , 1964, Archives of pathology.
[137] V. Cerundolo,et al. Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A , 2010, Nature Immunology.
[138] Yifan Cheng,et al. Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis , 2014, Proceedings of the National Academy of Sciences.
[139] J. Whitin,et al. Plasma Biomarkers in a Mouse Model of Preterm Labor , 2009, Pediatric Research.
[140] R. Badolato,et al. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes , 1994, The Journal of experimental medicine.
[141] G. Coetzee,et al. Serum Amyloid A Protein in Plasma: Characteristics of Acute Phase HDL , 1986 .
[142] V. Salomaa,et al. The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease--baseline findings of the PAIS project. , 2001, Atherosclerosis.
[143] C. Thorn,et al. Differential Glucocorticoid Enhancement of the Cytokine-Driven Transcriptional Activation of the Human Acute Phase Serum Amyloid A Genes, SAA1 and SAA2 , 2002, The Journal of Immunology.
[144] F. D. de Beer,et al. Serum Amyloid A Promotes Cholesterol Efflux Mediated by Scavenger Receptor B-I* , 2005, Journal of Biological Chemistry.
[145] A. Baldwin,et al. Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids , 1995, Science.
[146] Z. Ryoo,et al. Hepatic Serum Amyloid A1 Aggravates T Cell-mediated Hepatitis by Inducing Chemokines via Toll-like Receptor 2 in Mice* , 2015, The Journal of Biological Chemistry.
[147] K. Tracey,et al. Serum Amyloid A Stimulates PKR Expression and HMGB1 Release Possibly through TLR4/RAGE Receptors , 2015, Molecular medicine.
[148] S. Urieli-Shoval,et al. Serum amyloid A (SAA) treatment enhances the recovery of aggravated polymicrobial sepsis in mice, whereas blocking SAA’s invariant peptide results in early death , 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[149] N. Barzilai,et al. Hyperglycemia-induced Production of Acute Phase Reactants in Adipose Tissue* , 2001, The Journal of Biological Chemistry.
[150] F. Bäckhed,et al. Regulation of Serum Amyloid A3 (SAA3) in Mouse Colonic Epithelium and Adipose Tissue by the Intestinal Microbiota , 2009, PloS one.
[151] M. A. Larson,et al. Bovine serum amyloid A3 gene structure and promoter analysis: induced transcriptional expression by bacterial components and the hormone prolactin. , 2006, Gene.
[152] C. Brinckerhoff,et al. Autoregulation of collagenase production by a protein synthesized and secreted by synovial fibroblasts: cellular mechanism for control of collagen degradation. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[153] P. Ricciardi-Castagnoli,et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.
[154] D. Gabrilovich,et al. Myeloid-derived suppressor cells coming of age , 2018, Nature Immunology.
[155] G. Glenner,et al. Amino acid sequence of an amyloid fibril protein of unknown origin. , 1972, The Journal of biological chemistry.
[156] P. Cuatrecasas,et al. MURINE AMYLOID FIBRIL PROTEIN: ISOLATION, PURIFICATION AND CHARACTERIZATION , 1971, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[157] I. Vlodavsky,et al. In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[158] Shobini Jayaraman,et al. Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis , 2017, Proceedings of the National Academy of Sciences.
[159] L. Pauling,et al. Configurations of Polypeptide Chains With Favored Orientations Around Single Bonds: Two New Pleated Sheets. , 1951, Proceedings of the National Academy of Sciences of the United States of America.
[160] B. Bresnihan,et al. Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-kappaB-dependent signal transduction pathway. , 2006, Arthritis and rheumatism.
[161] N. Webb,et al. SAA does not induce cytokine production in physiological conditions. , 2013, Cytokine.
[162] M. A. Larson,et al. Induction of human mammary-associated serum amyloid A3 expression by prolactin or lipopolysaccharide. , 2003, Biochemical and biophysical research communications.
[163] A. Shakya,et al. Inflammation-Responsive Transcription Factor SAF-1 Activity Is Linked to the Development of Amyloid A Amyloidosis , 2006, The Journal of Immunology.
[164] R. Meek,et al. Expression of the third member of the serum amyloid A gene family in mouse adipocytes , 1989, The Journal of experimental medicine.
[165] R. H. Gross,et al. Increased level of translatable collagenase messenger ribonucleic acid in rabbit synovial fibroblasts treated with phorbol myristate acetate or crystals of monosodium urate monohydrate. , 1982, Biochemistry.
[166] Deepak Kumar,et al. Transcriptional Activity of Serum Amyloid A-activating Factor-1 Is Regulated by Distinct Functional Modules* , 2004, Journal of Biological Chemistry.
[167] M. Drumm,et al. Nonexpression of the human serum amyloid A three (SAA3) gene. , 1991, DNA and cell biology.
[168] S. Akira,et al. The role of NF-kappa B and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. , 1993, The Journal of biological chemistry.
[169] M. Hudson,et al. Antirheumatic drug use and the risk of acute myocardial infarction. , 2006, Arthritis and rheumatism.
[170] M. Fini,et al. Role of serum amyloid A as an intermediate in the IL-1 and PMA-stimulated signaling pathways regulating expression of rabbit fibroblast collagenase. , 1997, Experimental cell research.
[171] H. Lashuel,et al. From hexamer to amyloid: Marginal stability of apolipoprotein SAA2.2 leads to in vitro fibril formation at physiological temperature , 2005, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[172] T. Rutherford,et al. Serum amyloid A , 2010, Cancer.
[173] N. Eriksen,et al. Amyloid protein SAA is associated with high density lipoprotein from human serum. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[174] M. Hermodson,et al. The major proteins of human and monkey amyloid substance: Common properties including unusual N‐terminal amino acid sequences , 1971, FEBS letters.
[175] Han Remaut,et al. Bacterial amyloid formation: structural insights into curli biogensis. , 2015, Trends in microbiology.
[176] N. Kamatani,et al. Relative transcriptional activities of SAA1 promoters polymorphic at position −13(T/C): Potential association between increased transcription and amyloidosis , 2005, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[177] V. King,et al. Serum amyloid A in atherosclerosis , 2011, Current opinion in lipidology.
[178] C. Soto,et al. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis , 2000, Nature Medicine.
[179] P. Hawkins,et al. Changing epidemiology of AA amyloidosis: clinical observations over 25 years at a single national referral centre , 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[180] Ose,et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events* , 2002 .
[181] R. Yogev,et al. Cord Blood Acute Phase Reactants Predict Early Onset Neonatal Sepsis in Preterm Infants , 2017, PloS one.
[182] D. Schadendorf,et al. Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[183] E. Benditt,et al. Changes in high density lipoprotein content following endotoxin administration in the mouse. Formation of serum amyloid protein-rich subfractions. , 1982, The Journal of biological chemistry.
[184] H Patel,et al. Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis. , 1996, The Biochemical journal.
[185] Joseph A. DiDonato,et al. Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis , 1995, Science.
[186] C. Talbot,et al. The human serum amyloid A (SAA)-encoding gene GSAA1: nucleotide sequence and possible autocrine-collagenase-inducer function. , 1989, Gene.
[187] R. Ménard,et al. Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation , 2005, Annals of the rheumatic diseases.
[188] M. Zink,et al. Serum amyloid A gene transcription in synovial cells during retroviral arthritis. , 1992, The American journal of pathology.
[189] Whitehead,et al. The Kinetics and Magnitude of the Synergistic Activation of the Serum Amyloid A Promoter by IL‐1β and IL‐6 is Determined by the Order of Cytokine Addition , 1999, Scandinavian journal of immunology.
[190] M. Pepys. Pathogenesis, diagnosis and treatment of systemic amyloidosis. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[191] A. Robeva,et al. Serum Amyloid A (apoSAA) Expression Is Up-Regulated in Rheumatoid Arthritis and Induces Transcription of Matrix Metalloproteinases , 2001, The Journal of Immunology.
[192] P. Cohen,et al. Widespread Expression of Serum Amyloid A in Histologically Normal Human Tissues: Predominant Localization to the Epithelium , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[193] J. Liepnieks,et al. A pulse-chase study tracking the conversion of macrophage-endocytosed serum amyloid A into extracellular amyloid. , 2002, Arthritis and rheumatism.
[194] S. Urieli-Shoval,et al. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[195] W. Gong,et al. A Seven-transmembrane, G Protein–coupled Receptor, FPRL1, Mediates the Chemotactic Activity of Serum Amyloid A for Human Phagocytic Cells , 1999, The Journal of experimental medicine.
[196] H. Kitagawa,et al. Structural requirements of glycosaminoglycans for facilitating amyloid fibril formation of human serum amyloid A , 2016, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[197] G. Lozanski,et al. Induction of human serum amyloid A in Hep 3B cells by IL-6 and IL-1 beta involves both transcriptional and post-transcriptional mechanisms. , 1995, Journal of immunology.
[198] A. Chait,et al. Serum amyloid A: The “other” inflammatory protein , 2006, Current atherosclerosis reports.
[199] B. Ray,et al. A novel cis-acting element is essential for cytokine-mediated transcriptional induction of the serum amyloid A gene in nonhepatic cells , 1996, Molecular and cellular biology.
[200] M. Pras,et al. Degradation and deposition of amyloid AA fibrils are tissue specific. , 1987, Biochemistry.
[201] H. Brewer,et al. Serum amyloid A promotes ABCA1-dependent and ABCA1-independent lipid efflux from cells. , 2004, Biochemical and biophysical research communications.
[202] P. Westermark. Aspects on human amyloid forms and their fibril polypeptides , 2005, The FEBS journal.
[203] K. Migita,et al. Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[204] Muredach P. Reilly,et al. Inflammation Impairs Reverse Cholesterol Transport In Vivo , 2009, Circulation.
[205] J. Smith,et al. A monoclonal antibody sandwich immunoassay for serum amyloid A (SAA) protein. , 1991, Journal of immunological methods.
[206] Per Westermark,et al. Prion-like aggregates: infectious agents in human disease. , 2010, Trends in molecular medicine.
[207] H. O. D. op den Camp,et al. Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis. , 2008, Rheumatology.
[208] G. Kovacs,et al. Inflammatory protein serum amyloid A1 marks a subset of conventional renal cell carcinomas with fatal outcome. , 2010, European urology.
[209] B. Bresnihan,et al. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis. , 2004, Arthritis and rheumatism.
[210] J. Sipe,et al. Transcriptional Regulation of Serum Amyloid A1 Gene Expression in Human Aortic Smooth Muscle Cells Involves CCAAT/Enhancer Binding Proteins (C/EBP) and is Distinct From HepG2 Cells * , 2002, Scandinavian journal of immunology.
[211] C-Reactive Protein Levels and Outcomes after Statin Therapy , 2005 .
[212] C. Brinckerhoff,et al. Autocrine control of collagenase synthesis by synovial fibroblasts , 1988, Journal of cellular physiology.
[213] G. Getz,et al. Serum amyloid A and atherosclerosis , 2016, Current opinion in lipidology.
[214] Maria M. Lopez,et al. Serum amyloid A 2.2 refolds into a octameric oligomer that slowly converts to a more stable hexamer. , 2011, Biochemical and biophysical research communications.
[215] G. Sack. Molecular cloning of human genes for serum amyloid A. , 1983, Gene.
[216] N. Schweighofer,et al. Expression of serum amyloid A transcripts in human bone tissues, differentiated osteoblast‐like stem cells and human osteosarcoma cell lines , 2008, Journal of cellular biochemistry.
[217] L. Serpell,et al. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. , 1997, Journal of molecular biology.
[218] K. Miyake,et al. Serum Amyloid A3 Binds MD-2 To Activate p38 and NF-κB Pathways in a MyD88-Dependent Manner , 2013, The Journal of Immunology.
[219] K. Stubenrauch,et al. Advanced glycation end products and receptor for advanced glycation end products in AA amyloidosis. , 2003, The American journal of pathology.
[220] B. Schreiber,et al. Regulation of Extrahepatic Apolipoprotein Serum Amyloid A (ApoSAA) Gene Expression by Interleukin‐1α Alone: Synthesis and Secretion of ApoSAA by Cultured Aortic Smooth Muscle Cells , 1997, Scandinavian journal of immunology.
[221] L. Subrahmanyan,et al. Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[222] P. Westermark,et al. Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: Cross-seeding as a disease mechanism , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[223] S. O’Brien,et al. Molecular Analysis of the Human Serum Amyloid A (SAA) Gene Family , 1989, Scandinavian journal of immunology.
[224] G. Lavie,et al. Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes , 1978, The Journal of experimental medicine.
[225] R. Ye,et al. Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2. , 2014, Immunobiology.
[226] O. Gursky,et al. Structure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks , 2016, FEBS letters.
[227] J. Sipe. Revised nomenclature for serum amyloid A (SAA). Nomenclature Committee of the International Society of Amyloidosis. Part 2. , 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[228] D. Rateri,et al. Impact of serum amyloid A on high density lipoprotein composition and levels , 2010, Journal of Lipid Research.
[229] Y. Okuda,et al. Differential affinity of serum amyloid A1 isotypes for high-density lipoprotein , 2009, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[230] G. Getz,et al. Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro Published, JLR Papers in Press, November 1, 2003. DOI 10.1194/jlr.M300414-JLR200 , 2004, Journal of Lipid Research.
[231] P. Murphy,et al. Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains. , 1993, The Journal of biological chemistry.
[232] N. Eriksen,et al. Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[233] L. Moldawer,et al. MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis , 2007, The Journal of experimental medicine.
[234] T. Walz,et al. Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[235] K. Yasukawa,et al. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. , 1993, Science.
[236] R. Ye,et al. Serum amyloid A1: Structure, function and gene polymorphism. , 2016, Gene.
[237] M. Edbrooke,et al. Regulation of Human SAA Gene Expression by Cytokines , 1989 .
[238] M. Deeg,et al. Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients , 2004, Laboratory Investigation.
[239] L. Sullivan,et al. Serum amyloid A to monitor cancer dissemination. , 1979, Annals of internal medicine.
[240] Victor G Zgoda,et al. Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1 , 2005, Proteomics.
[241] V. King,et al. Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner. , 2008, The American journal of pathology.
[242] X. Gong,et al. Structure of the Human Lipid Exporter ABCA1 , 2017, Cell.
[243] S. Sabesin,et al. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. , 1989, Journal of lipid research.
[244] J. Nan,et al. Heparin interactions with apoA1 and SAA in inflammation-associated HDL. , 2016, Biochemical and biophysical research communications.
[245] D. Kastner,et al. Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy , 2009, British journal of haematology.
[246] R. Arsenescu,et al. Intestinal Epithelial Serum Amyloid A Modulates Bacterial Growth In Vitro and Pro-Inflammatory Responses in Mouse Experimental Colitis , 2010, BMC gastroenterology.
[247] Amos Tanay,et al. The Spectrum and Regulatory Landscape of Intestinal Innate Lymphoid Cells Are Shaped by the Microbiome , 2016, Cell.
[248] G. Glenner,et al. An amyloid fibril protein of unknown origin: partial amino-acid sequence analysis. , 1972, Biochemical and biophysical research communications.
[249] S. Kinkley,et al. The path of murine serum amyloid a through peritoneal macrophages , 2006, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[250] A. Szymańska,et al. Interaction of serum amyloid A with human cystatin C—assessment of amino acid residues crucial for hCC–SAA formation (part II) , 2013, Journal of molecular recognition : JMR.
[251] Nancy R Cook,et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. , 2002, The New England journal of medicine.
[252] M. A. Larson,et al. Differential expression and secretion of bovine serum amyloid A3 (SAA3) by mammary epithelial cells stimulated with prolactin or lipopolysaccharide. , 2005, Veterinary immunology and immunopathology.
[253] G. Sack,et al. Expression of serum amyloid A genes in mouse brain: unprecedented response to inflammatory mediators , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[254] J. Kwak,et al. Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells. , 2005, Biochemical and biophysical research communications.
[255] A. Whitehead,et al. Biosynthesis of human acute-phase serum amyloid A protein (A-SAA) in vitro: the roles of mRNA accumulation, poly(A) tail shortening and translational efficiency. , 1993, The Biochemical journal.
[256] J. Johnston,et al. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway. , 1995, Journal of immunology.
[257] R. Ye,et al. Cutting Edge: TLR2 Is a Functional Receptor for Acute-Phase Serum Amyloid A1 , 2008, The Journal of Immunology.
[258] M. Pras,et al. The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. , 1972, The Journal of clinical investigation.
[260] P. Heeringa,et al. Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A2[S] , 2010, Journal of Lipid Research.
[261] Matthew R. Jones,et al. Mechanisms of the Hepatic Acute-Phase Response during Bacterial Pneumonia , 2009, Infection and Immunity.
[262] G. Getz,et al. SAA, HDL biogenesis, and inflammation1 , 2008, Journal of Lipid Research.
[263] Roland Riek,et al. The activities of amyloids from a structural perspective , 2016, Nature.
[264] H. Colten,et al. Structure of a human serum amyloid A gene and modulation of its expression in transfected L cells. , 1987, The Journal of biological chemistry.
[265] Fellowes,et al. Human Serum Amyloid A has Cytokine‐Like Properties , 1998, Scandinavian journal of immunology.
[266] G. Coetzee,et al. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. , 1986, The Journal of biological chemistry.
[267] D. Luk,et al. Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro , 1993, Molecular and cellular biology.
[268] W. Liao,et al. NFκB Interacts with Serum Amyloid A3 Enhancer Factor to Synergistically Activate Mouse Serum Amyloid A3 Gene Transcription* , 2000, The Journal of Biological Chemistry.
[269] F. Noborn,et al. Heparan Sulfate Dissociates Serum Amyloid A (SAA) from Acute-phase High-density Lipoprotein, Promoting SAA Aggregation* , 2012, The Journal of Biological Chemistry.
[270] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[271] C. Serhan,et al. Aspirin-Triggered Lipoxins Override the Apoptosis-Delaying Action of Serum Amyloid A in Human Neutrophils: A Novel Mechanism for Resolution of Inflammation1 , 2007, The Journal of Immunology.
[272] I. Narita,et al. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in both AA amyloidosis associated with rheumatoid arthritis and AL amyloidosis , 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[273] James M Robins,et al. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study , 2002, The Lancet.
[274] M. Groudine,et al. Regulation of amyloid A gene expression in cultured cells , 1988, Molecular and cellular biology.
[275] C. Trautwein,et al. Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man , 2007, The Journal of experimental medicine.
[276] B. Schreiber,et al. Secretory Phospholipase A2, Group IIA Is a Novel Serum Amyloid A Target Gene , 2009, The Journal of Biological Chemistry.
[277] D. Mack,et al. Human serum amyloid A3 peptide enhances intestinal MUC3 expression and inhibits EPEC adherence. , 2003, Biochemical and biophysical research communications.
[278] S. Oba-Shinjo,et al. Serum amyloid A1 is upregulated in human glioblastoma , 2017, Journal of Neuro-Oncology.
[279] R. Yung,et al. Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2. , 2010, American journal of respiratory and critical care medicine.
[280] R. Ye,et al. Ex Vivo and In Vitro Effect of Serum Amyloid A in the Induction of Macrophage M2 Markers and Efferocytosis of Apoptotic Neutrophils , 2015, The Journal of Immunology.
[281] Vishva M. Dixit,et al. Mechanisms and Functions of Inflammasomes , 2014, Cell.